201 related articles for article (PubMed ID: 1115123)
1. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity.
Grattarola R; Secreto G; Recchione C
Am J Obstet Gynecol; 1975 Jan; 121(2):169-72. PubMed ID: 1115123
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy.
Secreto G; Zumoff B
Cancer Res; 1983 Jul; 43(7):3408-11. PubMed ID: 6850646
[TBL] [Abstract][Full Text] [Related]
3. What is the place of hormones in prophylaxis after mastectomy?
Hayward JL
Br J Surg; 1969 Oct; 56(10):794-6. PubMed ID: 5347588
[TBL] [Abstract][Full Text] [Related]
4. Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast.
Gratterola R
Cancer Res; 1978 Sep; 38(9):3051-4. PubMed ID: 679211
[TBL] [Abstract][Full Text] [Related]
5. Impact of immediate reconstruction on the local recurrence of breast cancer after mastectomy.
Murphy RX; Wahhab S; Rovito PF; Harper G; Kimmel SR; Kleinman LC; Young MJ
Ann Plast Surg; 2003 Apr; 50(4):333-8. PubMed ID: 12671371
[TBL] [Abstract][Full Text] [Related]
6. Urinary androgen excretion and the etiology of breast cancer.
Bulbrook RD
J Natl Cancer Inst; 1972 Apr; 48(4):1039-42. PubMed ID: 5023673
[No Abstract] [Full Text] [Related]
7. [Hormonal prevention of recurrence and metastasis in the complex treatment of breast cancer].
Vishniakova EG
Vopr Onkol; 1968; 14(3):74-9. PubMed ID: 4968229
[No Abstract] [Full Text] [Related]
8. [Follow-up of breast cancer: review of 750 cases after 5 years].
Martínez-Regueira F; Díez-Caballero A; Sierra A; Espí A; Baixauli J; Zornoza A
Rev Med Univ Navarra; 1998; 42(1):7-13. PubMed ID: 10420951
[TBL] [Abstract][Full Text] [Related]
9. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
Willner J; Kiricuta IC; Kölbl O
Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
[TBL] [Abstract][Full Text] [Related]
10. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
11. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
[TBL] [Abstract][Full Text] [Related]
12. Increased androgenic activity and breast cancer risk in premenopausal women.
Secreto G; Toniolo P; Berrino F; Recchione C; Di Pietro S; Fariselli G; Decarli A
Cancer Res; 1984 Dec; 44(12 Pt 1):5902-5. PubMed ID: 6498847
[TBL] [Abstract][Full Text] [Related]
13. Comparison of prophylactic and therapeutic castration in breast carcinoma.
Fracchia AA; Murray DR; Farrow JH; Balachandra VK
Surg Gynecol Obstet; 1969 Aug; 129(2):270-6. PubMed ID: 5794401
[No Abstract] [Full Text] [Related]
14. The preferred treatment for young women with breast cancer--mastectomy versus breast conservation.
van Nes JG; van de Velde CJ
Breast; 2006 Dec; 15 Suppl 2():S3-10. PubMed ID: 17382859
[TBL] [Abstract][Full Text] [Related]
15. [Should chest wall irradiation be included after mastectomy and negative node breast cancer?].
Ben Ammar CN; Kochbati L; Chraeit N; Amrouche A; Gargouri W; Frikha H; Besbes M; Abdallah MB; Maalej M
Cancer Radiother; 2008 Mar; 12(2):73-7. PubMed ID: 18243752
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary androgen excretion is a hormonal abnormality detectable before the clinical onset of breast cancer.
Secreto G; Recchione C; Grignolio E; Cavalleri A
Cancer Detect Prev; 1983; 6(4-5):435-8. PubMed ID: 6652637
[TBL] [Abstract][Full Text] [Related]
17. [Value of cyto-hormonal smears in the conduct of androgenic treatment of women with breast cancer].
Marsan C; Sicard A
Presse Med (1893); 1969 Dec; 77(54):2033-6. PubMed ID: 5378459
[No Abstract] [Full Text] [Related]
18. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.
de Bock GH; van der Hage JA; Putter H; Bonnema J; Bartelink H; van de Velde CJ
Eur J Cancer; 2006 Feb; 42(3):351-6. PubMed ID: 16314086
[TBL] [Abstract][Full Text] [Related]
19. Recurrence in breast cancer. Analysis with frailty model.
Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
[TBL] [Abstract][Full Text] [Related]
20. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
Sacchini V; Pinotti JA; Barros AC; Luini A; Pluchinotta A; Pinotti M; Boratto MG; Ricci MD; Ruiz CA; Nisida AC; Veronesi P; Petit J; Arnone P; Bassi F; Disa JJ; Garcia-Etienne CA; Borgen PI
J Am Coll Surg; 2006 Nov; 203(5):704-14. PubMed ID: 17084333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
